person · Reporting owner
Ellinor Patrick Thomas II
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Editas Medicine, Inc.EDIT · Entity 5502 | Director | August 06, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Editas Medicine, Inc.
Report date August 06, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.90 · Expires 2036-08-05 | Direct | 103,400 |
Reported balance
After 2026-08-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-06 · Grant · Acquired 103,400 · Balance 103,400 F1: This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2026 Filed Aug 7, 2026 21:16 UTC | Editas Medicine, Inc. EDIT · Entity 5502 | GrantStock Option (right to buy) · Derivative | 103,400 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0002137699-26-000004 · wk-form4_1786137389.xml · derivative · entry 1 Ellinor Patrick Thomas II · CIK 0002137699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,400 Underlying: Common Stock · 103,400 shares Expires 2036-08-05 F1 · derivative.exercise_date: This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.